Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1197338

Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study

Grubišić, Frane; Grazio, Simeon; Anić, Branimir; Barešić, Marko; Novak, Srđan; Anić, Felina; Prus, Višnja; Gudelj Gračanin, Ana; Morović-Vergles, Jadranka; Martinović-Kaliterna, Danijela et al.
Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study // nternational Journal of Rheumatic Diseases
Dubai, Ujedinjeni Arapski Emirati, 2017. str. 51-51 (poster, međunarodna recenzija, sažetak, znanstveni)

CROSBI ID: 1197338 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study

Autori
Grubišić, Frane ; Grazio, Simeon ; Anić, Branimir ; Barešić, Marko ; Novak, Srđan ; Anić, Felina ; Prus, Višnja ; Gudelj Gračanin, Ana ; Morović-Vergles, Jadranka ; Martinović-Kaliterna, Danijela ; Borić, Katarina ; Kehler, Tatjana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Nternational Journal of Rheumatic Diseases / - , 2017, 51-51

Skup
19th Asia Pacific League of Associations for Rheumatology Congress – APLAR 2017 and 3rd Annual Conference of the Emirates Society for Rheumatology – ESR

Mjesto i datum
Dubai, Ujedinjeni Arapski Emirati, 16.10.2017. - 20.10.2017

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
biosimilar ; infliximab ; ankylosing spondylitis ;

Sažetak
The aim of the study was to evaluate the efficacy and safety of biosimilar Inflectra in patients with AS.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA

Ustanove:
Klinički bolnički centar Osijek,
KBC "Sestre Milosrdnice",
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb,
Klinički bolnički centar Rijeka

Profili:

Avatar Url Katarina Borić (autor)

Avatar Url Marko Barešić (autor)

Avatar Url Višnja Prus (autor)

Avatar Url Frane Grubišić (autor)

Avatar Url Simeon Grazio (autor)

Avatar Url Branimir Anić (autor)

Avatar Url Srđan Novak (autor)

Avatar Url Tatjana Kehler (autor)

Avatar Url Jadranka Morović-Vergles (autor)

Avatar Url Felina Anić (autor)

Avatar Url Ana Gudelj Gračanin (autor)

Citiraj ovu publikaciju:

Grubišić, Frane; Grazio, Simeon; Anić, Branimir; Barešić, Marko; Novak, Srđan; Anić, Felina; Prus, Višnja; Gudelj Gračanin, Ana; Morović-Vergles, Jadranka; Martinović-Kaliterna, Danijela et al.
Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study // nternational Journal of Rheumatic Diseases
Dubai, Ujedinjeni Arapski Emirati, 2017. str. 51-51 (poster, međunarodna recenzija, sažetak, znanstveni)
Grubišić, F., Grazio, S., Anić, B., Barešić, M., Novak, S., Anić, F., Prus, V., Gudelj Gračanin, A., Morović-Vergles, J. & Martinović-Kaliterna, D. (2017) Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study. U: nternational Journal of Rheumatic Diseases.
@article{article, author = {Grubi\v{s}i\'{c}, Frane and Grazio, Simeon and Ani\'{c}, Branimir and Bare\v{s}i\'{c}, Marko and Novak, Sr\djan and Ani\'{c}, Felina and Prus, Vi\v{s}nja and Gudelj Gra\v{c}anin, Ana and Morovi\'{c}-Vergles, Jadranka and Martinovi\'{c}-Kaliterna, Danijela and Bori\'{c}, Katarina and Kehler, Tatjana}, year = {2017}, pages = {51-51}, keywords = {biosimilar, infliximab, ankylosing spondylitis, }, title = {Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study}, keyword = {biosimilar, infliximab, ankylosing spondylitis, }, publisherplace = {Dubai, Ujedinjeni Arapski Emirati} }
@article{article, author = {Grubi\v{s}i\'{c}, Frane and Grazio, Simeon and Ani\'{c}, Branimir and Bare\v{s}i\'{c}, Marko and Novak, Sr\djan and Ani\'{c}, Felina and Prus, Vi\v{s}nja and Gudelj Gra\v{c}anin, Ana and Morovi\'{c}-Vergles, Jadranka and Martinovi\'{c}-Kaliterna, Danijela and Bori\'{c}, Katarina and Kehler, Tatjana}, year = {2017}, pages = {51-51}, keywords = {biosimilar, infliximab, ankylosing spondylitis, }, title = {Efficacy and safety of biosimilar (Inflectra) in patients with ankylosing spondylitis: multicenter and observational one year follow-up study}, keyword = {biosimilar, infliximab, ankylosing spondylitis, }, publisherplace = {Dubai, Ujedinjeni Arapski Emirati} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.